Indo-MIM IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Jul 23 to Jul 27 2026
Price Band
₹461 - 485
Current GMP
₹700.0 (+44.33%)
Subscription
72.37 times
IPO Details
| IPO Date | 23 to 27 Jul, 2026 |
| Listing Date | Thu, Jul 30, 2026 |
| Face Value | ₹ 1 per share |
| Price Band | ₹461 to ₹485 |
| Issue Price | ₹485 per share |
| Lot Size | 30 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Employee Discount | ₹ 45.00 |
| Total Issue Size | 7,86,00,300 shares (agg. up to ₹ 3,811 Cr) |
| Fresh Issue | 1,03,09,278 shares (agg. up to ₹ 499 Cr) |
| Offer for Sale | 6,82,91,022 shares of ₹ 1 (agg. up to ₹ 3,311 Cr) |
| Share Holding Pre Issue | 48,41,53,072 shares |
| Share Holding Post Issue | 49,44,62,350 shares |
| BSE Script Code / NSE Symbol | 544837 / INDOMIM |
| ISIN | INE084101034 |
IPO Date
23 to 27 Jul, 2026
Listing Date
Thu, Jul 30, 2026
Face Value
₹ 1 per share
Price Band
₹461 to ₹485
Issue Price
₹485 per share
Lot Size
30 Shares
Sale Type
Fresh capital cum OFS
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE
Employee Discount
₹ 45.00
Total Issue Size
7,86,00,300 shares (agg. up to ₹ 3,811 Cr)
Fresh Issue
1,03,09,278 shares (agg. up to ₹ 499 Cr)
Offer for Sale
6,82,91,022 shares of ₹ 1 (agg. up to ₹ 3,311 Cr)
Share Holding Pre Issue
48,41,53,072 shares
Share Holding Post Issue
49,44,62,350 shares
BSE Script Code / NSE Symbol
544837 / INDOMIM
ISIN
INE084101034
IPO Subscription Details
| Anchor | 1 |
| QIB (Ex Anchor) | 204.47 |
| NII | 50.64 |
| bNII (> ₹10L) | 57.69 |
| sNII (< ₹10L) | 36.54 |
| Retail | 6.69 |
| Employees | 9.44 |
| Total ** | 72.37 |
Anchor
1
QIB (Ex Anchor)
204.47
NII
50.64
bNII (> ₹10L)
57.69
sNII (< ₹10L)
36.54
Retail
6.69
Employees
9.44
Total **
72.37
Day Wise Sub
| Day | QIB (Ex Anchor) | NII | NII (> ₹10L) | NII (< ₹10L) | Retail | EMP | Total |
|---|---|---|---|---|---|---|---|
| Jul 2 3 (Day 1) | 0.18 | 3.04 | 2.75 | 3.61 | 0.88 | 1.51 | 1.14 |
| Jul 2 4 (Day 2) | 1.11 | 8.45 | 8.27 | 8.81 | 1.90 | 3.03 | 3.08 |
| Jul 2 7 (Day 3) | 204.47 | 50.64 | 57.69 | 36.54 | 6.69 | 9.44 | 72.37 |
DayJul 2
3 (Day 1)
QIB (Ex Anchor)0.18
NII3.04
NII (> ₹10L)2.75
NII (< ₹10L)3.61
Retail0.88
EMP1.51
Total1.14
DayJul 2
4 (Day 2)
QIB (Ex Anchor)1.11
NII8.45
NII (> ₹10L)8.27
NII (< ₹10L)8.81
Retail1.90
EMP3.03
Total3.08
DayJul 2
7 (Day 3)
QIB (Ex Anchor)204.47
NII50.64
NII (> ₹10L)57.69
NII (< ₹10L)36.54
Retail6.69
EMP9.44
Total72.37
Day Wise GMP
| GMP Date | IPO Price | GMP | Est. Listing Price |
|---|---|---|---|
| 30-07-2026 | 485 | 184 (37.94%) | 669 |
| 29-07-2026 | 485 | 187 (38.56%) | 672 |
| 28-07-2026 | 485 | 190 (39.18%) | 675 |
| 27-07-2026 | 485 | 190 (39.18%) | 675 |
| 26-07-2026 | 485 | 190 (39.18%) | 675 |
| 25-07-2026 | 485 | 181 (37.32%) | 666 |
| 24-07-2026 | 485 | 184 (37.94%) | 669 |
| 23-07-2026 | 485 | 170 (35.05%) | 655 |
| 22-07-2026 | 485 | 185 (38.14%) | 670 |
| 21-07-2026 | 485 | 194 (40.00%) | 679 |
| 20-07-2026 | 485 | 195 (40.21%) | 680 |
| 19-07-2026 | 0 | 213 (0%) | 213 |
| 18-07-2026 | 0 | 168 (0%) | 168 |
GMP Date30-07-2026
IPO Price485
GMP184 (37.94%)
Est. Listing Price669
GMP Date29-07-2026
IPO Price485
GMP187 (38.56%)
Est. Listing Price672
GMP Date28-07-2026
IPO Price485
GMP190 (39.18%)
Est. Listing Price675
GMP Date27-07-2026
IPO Price485
GMP190 (39.18%)
Est. Listing Price675
GMP Date26-07-2026
IPO Price485
GMP190 (39.18%)
Est. Listing Price675
GMP Date25-07-2026
IPO Price485
GMP181 (37.32%)
Est. Listing Price666
GMP Date24-07-2026
IPO Price485
GMP184 (37.94%)
Est. Listing Price669
GMP Date23-07-2026
IPO Price485
GMP170 (35.05%)
Est. Listing Price655
GMP Date22-07-2026
IPO Price485
GMP185 (38.14%)
Est. Listing Price670
GMP Date21-07-2026
IPO Price485
GMP194 (40.00%)
Est. Listing Price679
GMP Date20-07-2026
IPO Price485
GMP195 (40.21%)
Est. Listing Price680
GMP Date19-07-2026
IPO Price0
GMP213 (0%)
Est. Listing Price213
GMP Date18-07-2026
IPO Price0
GMP168 (0%)
Est. Listing Price168
IPO Important Dates
| IPO Open | Thu, Jul 23, 2026 |
| IPO Close | Mon, Jul 27, 2026 |
| Allotment | Tue, Jul 28, 2026 |
| Refund | Wed, Jul 29, 2026 |
| Credit of Shares | Wed, Jul 29, 2026 |
| Listing | Thu, Jul 30, 2026 |
IPO Open
Thu, Jul 23, 2026
IPO Close
Mon, Jul 27, 2026
Allotment
Tue, Jul 28, 2026
Refund
Wed, Jul 29, 2026
Credit of Shares
Wed, Jul 29, 2026
Listing
Thu, Jul 30, 2026
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 30 | ₹14,550 |
| Retail (Max) | 13 | 390 | ₹1,89,150 |
| S-HNI (Min) | 14 | 420 | ₹2,03,700 |
| S-HNI (Max) | 68 | 2,040 | ₹9,89,400 |
| B-HNI (Min) | 69 | 2,070 | ₹10,03,950 |
ApplicationRetail (Min)
Lots1
Shares30
Amount₹14,550
ApplicationRetail (Max)
Lots13
Shares390
Amount₹1,89,150
ApplicationS-HNI (Min)
Lots14
Shares420
Amount₹2,03,700
ApplicationS-HNI (Max)
Lots68
Shares2,040
Amount₹9,89,400
ApplicationB-HNI (Min)
Lots69
Shares2,070
Amount₹10,03,950
Financial Information
| Period Ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 4,897.33 | 4,140.84 | 3,757.51 |
| Total Income | 4,320.70 | 3,373.97 | 2,900.38 |
| Profit After Tax | 533.54 | 423.73 | 283.73 |
| EBITDA | 1,070.92 | 932.60 | 743.46 |
| NET Worth | 2,819.55 | 2,199.43 | 2,050.51 |
| Reserves and Surplus | 2,573.46 | 2,030.81 | 1,889.04 |
| Total Borrowing | 1,090.49 | 1,247.20 | 1,085.01 |
Period EndedAssets
31 Mar 20264,897.33
31 Mar 20254,140.84
31 Mar 20243,757.51
Period EndedTotal Income
31 Mar 20264,320.70
31 Mar 20253,373.97
31 Mar 20242,900.38
Period EndedProfit After Tax
31 Mar 2026533.54
31 Mar 2025423.73
31 Mar 2024283.73
Period EndedEBITDA
31 Mar 20261,070.92
31 Mar 2025932.60
31 Mar 2024743.46
Period EndedNET Worth
31 Mar 20262,819.55
31 Mar 20252,199.43
31 Mar 20242,050.51
Period EndedReserves and Surplus
31 Mar 20262,573.46
31 Mar 20252,030.81
31 Mar 20241,889.04
Period EndedTotal Borrowing
31 Mar 20261,090.49
31 Mar 20251,247.20
31 Mar 20241,085.01
Key Performance Indicator
| ROE | 21.26% |
| ROCE | 26.60% |
| Debt/Equity | 0.39 |
| RoNW | 21.26% |
| PAT Margin | 12.72% |
| EBITDA Margin | 25.54% |
| NAV | 58.24 |
| Price to Book Value |
ROE
21.26%
ROCE
26.60%
Debt/Equity
0.39
RoNW
21.26%
PAT Margin
12.72%
EBITDA Margin
25.54%
NAV
58.24
Price to Book Value
IPO Reservation
| QIB Shares Offered | 3,92,00,150 |
| − Anchor Investor Shares Offered | 2,35,25,656 |
| − QIB (Ex. Anchor) Shares Offered | 1,56,74,494 |
| NII (HNI) Shares Offered | 1,17,60,045 |
| − bNII > ₹10L | 78,40,030 |
| − sNII < ₹10L | 39,20,015 |
| Retail Shares Offered | 2,74,40,105 |
| Employee Shares Offered | 2,00,000 |
| Total Shares Offered | 7,86,00,300 |
QIB Shares Offered
3,92,00,150
− Anchor Investor Shares Offered
2,35,25,656
− QIB (Ex. Anchor) Shares Offered
1,56,74,494
NII (HNI) Shares Offered
1,17,60,045
− bNII > ₹10L
78,40,030
− sNII < ₹10L
39,20,015
Retail Shares Offered
2,74,40,105
Employee Shares Offered
2,00,000
Total Shares Offered
7,86,00,300
Information about company
Incorporated in 1996, Indo-MIM is a global leader in manufacturing precision engineering components using metal injection molding (MIM) technology. The company offers end-to-end solutions including mold design, tooling, finishing, and assembly.
Along with MIM, the company also use advanced technologies such as investment casting, precision machining, ceramic injection molding, and 3D metal printing to serve diverse industries. In FY 2025, it has manufactured over 6,400 products, catering to automotive, defence, medica, consumer, and aerospace industries.
Product Portfolio :
The company has global sales capabilities with a dedicated sales team that provides customer support. As of March 31, 2026, it has three sales offices in China, Germany and the United States, with 13 sales representatives in Czech Republic, France, Italy, Japan, South Korea, Israel, Poland and Turkey. In Fiscal 2026, it has served more than 1,100 customers
Manufacturing: The company operates 15 manufacturing facilities across India, the US, the UK, and Mexico, and hold the world’s largest installed MIM capacity (Source: F&S Report). Its global presence includes sales offices in China, Germany, and the US, and sales representatives across Europe and Asia.
Competitive Strengths
Objectives of IPO
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
#: Issue Objects
1: Repayment/ prepayment, in full or part, of all or certain outstanding borrowings availed by Company
2: General Corporate Purposes
: Total
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App